Federal Register / Vol. 76, No. 64 / Monday, April 4, 2011 / Notices 18553 

others were available in July 2010. The 

Office of the Assistant Secretary of 

Preparedness and Response (ASPR) 

within the Department of Health and 

Human Services (HHS) is submitting 

this document for public consideration 

as the lead agency in a broad 

interagency process to draft the 

implementation plan. 

DATES: The public is encouraged to 

submit written comments on this 

proposed document. Comments may be 

submitted to HHS/ASPR in electronic 

form at the HHS/ASPR e-mail address 

and URL shown below. All comments 

should be submitted by April 18, 2011. 

All written comments received in 

response to this notice will be available 

for review by request. This document is 

available in hard-copy for all those that 

request it from the federal point of 

contact. 

FOR FURTHER INFORMATION CONTACT: Lisa 

Kaplowitz, Deputy Assistant Secretary, 

Office of Policy and Planning, Office of 

the Assistant Secretary for Preparedness 

and Response, U.S. Department of 

Health and Human Services, 200 

Independence Avenue, SW., 

Washington, DC 20201; phone: 202– 

205–2882; http://www.phe.gov/nhss; 

e-mail address: nhss@hhs.gov. 

SUPPLEMENTARY INFORMATION: 

The National Health Security Strategy 

(2009) can be found at: http:// 

www.phe.gov/Preparedness/planning/ 

authority/nhss/Pages/default.aspx. 

Dated: March 28, 2011. 

Nicole Lurie, 

Assistant Secretary for Preparedness and 

Response. 

[FR Doc. 2011–7881 Filed 4–1–11; 8:45 am] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30 Day–11–11BP] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC 20503 or by fax to (202) 395–5806. 

Written comments should be received 

within 30 days of this notice. 

Proposed Project 

Community-based Organization (CBO) 

Monitoring and Evaluation Project 

(CMEP) of Women Involved in Life 

Learning from Other Women 

(WILLOW)—New—National Center for 

HIV/AIDS, Viral Hepatitis, STD, and TB 

Prevention (NCHHSTP) 

Background and Brief Description 

CDC began formally partnering with 

CBOs in the late 1980s to expand the 

reach of HIV prevention efforts. CBOs 

were, and continue to be, recognized as 

important partners in HIV prevention 

because of their history and credibility 

with target populations and their access 

to groups that may not be easily 

reached. Over time, CDC’s program for 

HIV prevention by CBOs has grown in 

size, scope, and complexity to respond 

to changes in the epidemic, including 

the diffusion and implementation of 

Effective Behavioral Interventions (EBIs) 

for HIV prevention. Women Involved in 

Life Learning from Other Women 

(WILLOW) is an EBI that focuses on 

health education and social skills 

building among women living with HIV. 

CDC’s EBIs have been shown to be 

effective under controlled research 

environments, but there is limited data 

on intervention implementation and 

client outcomes in real-world settings 

(as implemented by CDC-funded CBOs). 

The purpose of CMEP is to improve the 

performance of CDC-funded CBOs 

delivering particular individual- or 

group-level behavioral interventions. 

This is done by monitoring changes in 

clients’ self-reported HIV transmission 

risk behaviors after participating in the 

intervention. CMEP also assesses the 

fidelity of the implementation of the 

selected intervention at the CBO. The 

project also plans to conduct process 

monitoring of the delivery of the 

intervention in terms of recruitment, 

retention, and data collection, entry, 

and management. Four CBOs will 

receive supplemental funding under PS 

10–1003 over a five-year period to 

participate in CMEP–WILLOW. 

From July 1, 2011 to June 30, 2015, 

CBOs will conduct outcome and process 

monitoring for this project. Each agency 

will recruit 400 women living with HIV 

who are 18 years of age and older, have 

known their positive HIV status for at 

least 6 months, and are enrolled in the 

WILLOW intervention to participate in 

CMEP–WILLOW. Each participant will 

complete a 20 minute, self 

administered, computer based interview 

prior to their participation in the 

WILLOW intervention and an 18 

minute, self administered, computer 

based interview at two follow-up time 

points (90- and 180-days following the 

WILLOW intervention) to assess their 

HIV-related attitudes and behavioral 

risks. CBOs will be expected to retain 

80% of these participants at both 

follow-up interviews. 

Throughout the project, funded CBOs 

will be responsible for managing the 

daily procedures of CMEP–WILLOW to 

ensure that all required activities are 

performed, all deadlines are met, and 

quality assurance plans, policies and 

procedures are upheld. CBOs will be 

responsible for participating in all CDCsponsored grantee meetings related to 

CMEP–WILLOW. The total estimated 

annual burden hours are 338. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondent Form Number of respondents 

Number of responses per 

respondent 

Average burden response 

(in hours) 

General population .......................................... Screener ......................................................... 400 1 2/60 

General population .......................................... Baseline Interview .......................................... 400 1 20/60 

General population .......................................... 90-Day Follow-Up Interview ........................... 320 1 18/60 

General population .......................................... 180-Day Follow-Up Interview ......................... 320 1 18/60 


Emcdonald on DSK2BSOYB1PROD with NOTICES
18554 Federal Register / Vol. 76, No. 64 / Monday, April 4, 2011 / Notices 

Daniel Holcomb, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2011–7888 Filed 4–1–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-11–11DT] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 or send 

comments to Daniel Holcomb, CDC 

Reports Clearance Officer, 1600 Clifton 

Road, MS–D74, Atlanta, GA 30333 or 

send an e-mail to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Monitoring Outcomes of the 

Enhanced Comprehensive HIV 

Prevention Planning (ECHPP) ProjectNew-National Center for HIV/AIDS, 

Viral Hepatitis, STD, and TB Prevention 

(NCHHSTP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The scope of the HIV epidemic in the 

United States is significant, particularly 

in large urban areas where HIV/AIDS 

cases are concentrated. In 2006, 

approximately 56,000 new HIV 

infections occurred in the U.S., 

demonstrating the need to expand 

targeted HIV prevention efforts. In 2010, 

twelve U.S. metropolitan statistical 

areas (MSAs) received funding, through 

their city and state health departments, 

to conduct the Enhanced 

Comprehensive HIV Prevention 

Planning (ECHPP) project. These twelve 

MSAs (Atlanta, GA; Baltimore, MD; 

Chicago, IL; Dallas, TX; District of 

Columbia; Houston, TX; Los Angeles, 

CA; Miami, FL; New York City, NY; 

Philadelphia, PA; San Francisco, CA; 

and San Juan, PR) had the highest AIDS 

prevalence rates in the U.S. at the end 

of 2007, representing 44% of all U.S. 

AIDS cases. The purpose of ECHPP is to 

enhance existing HIV prevention 

services in these high prevalence areas 

and provide an optimal mix of 

evidence-based behavioral, biomedical, 

and structural interventions to have 

maximum impact on the HIV/AIDS 

epidemic at the community level. 

ECHPP goals are consistent with CDC’s 

Division of HIV/AIDS Prevention 

Strategic Plan for HIV Prevention and 

with the National HIV/AIDS Strategy: 

(1) Prevent new HIV infections, (2) 

increase linkage to, and impact of, 

prevention and care services for HIVpositive individuals, and (3) reduce 

HIV-related health disparities. 

To evaluate ECHPP, data will be 

collected through both existing CDC 

data sources and through new data 

collection activities. Existing CDC data 

sources will include HIV surveillance 

systems (e.g., National HIV Behavioral 

Surveillance System, Medical 

Monitoring Project) that routinely 

collect information about behavioral 

and clinical outcomes from at-risk target 

populations in the 12 MSAs. A new data 

collection activity is proposed through 

this project to collect information about 

behavioral and clinical outcomes from 

injection drug users, high-risk 

heterosexuals, and HIV-positive 

individuals who access medical care in 

six of the 12 ECHPP-funded MSAs. 

These MSAs are: District of Columbia; 

Houston, TX; Los Angeles, CA; Miami, 

FL; New York City, NY; and San 

Francisco, CA. The purpose of this new 

data collection activity is to monitor 

community-level outcomes of ECHPP 

and supplement HIV surveillance data 

routinely collected in these areas. 

Outcome data will be collected in these 

MSAs at two time points from 2011 to 

2014. 

Two surveys will be used in this 

project: (1) A community-based survey 

to be administered to injection drug 

users and high-risk heterosexuals, and 

(2) a clinic-based survey to be 

administered to HIV-positive 

individuals seeking care at clinics that 

provide HIV-related services. Both 

surveys will collect data on 

demographics, sexual behavior, alcohol 

and drug use history, HIV testing 

experiences, exposure to HIV 

prevention messages, and participation 

in HIV prevention activities. The clinic 

survey will also include questions about 

HIV treatment, treatment adherence, 

sources of care, and medical outcomes. 

For the community survey, we intend to 

recruit and screen 1500 injection drug 

users and 1500 high-risk heterosexuals 

using venue-based, convenience 

sampling methods. For the clinic 

survey, we intend to recruit and screen 

2400 HIV-positive individuals seeking 

HIV care at medical clinics. A total of 

1200 eligible injection drug users (age ≥ 

18 yrs), 1200 eligible high-risk 

heterosexuals (age 18 to 60 yrs), and 

2400 eligible HIV-positive individuals 

(age ≥ 18 yrs) will be surveyed. CDC will 

collaborate with local health department 

staff and outreach workers in each MSA 

to identify venues and clinics 

appropriate for data collection. Surveys 

will be administered by trained, local 

interviewers. There is no cost to 

respondents other than their time. 

ESTIMATE OF ANNUALIZED BURDEN TABLE

Target population Data collection form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Injection drug users ............................................ Community Screener ...... 500 1 5/60 42 

Eligible injection drug users ................................ Community Survey ......... 400 1 25/60 167 

High-risk heterosexual individuals ...................... Community Screener ...... 500 1 5/60 42 

Eligible high-risk heterosexual individuals .......... Community Survey ......... 400 1 25/60 167 

HIV-positive individuals ....................................... Clinic Screener ............... 933 1 5/60 78 


Emcdonald on DSK2BSOYB1PROD with NOTICES